Centrillion Biosciences

Centrillion Technologies, formerly known as Centrillion Biosciences, is a life sciences company that has developed a range of genomics and DNA analysis technologies. The company focuses on creating tools for genomic studies, which include sequencing, bioinformatics solutions, and a new generation of DNA chips. These chips are designed to be compatible with sequencing and combine high-density with high-quality probes, addressing critical issues in large-scale genomic analysis.

Centrillion serves clients in the drug discovery and life sciences research sectors. Its business model is centered on providing these tools and services to other businesses and research institutions. The company generates revenue through the sale of its products, such as the ATOM™, a high-throughput detection system, and the VirusHunter™ MVP assay for detecting pathogens like SARS-CoV-2 and Influenza. Additionally, Centrillion offers molecular and genomics services, including sequencing and droplet digital PCR, further supporting its B2B model.

Keywords: genomics, DNA analysis, high-throughput detection, DNA chips, bioinformatics, sequencing, life sciences, drug discovery, personalized medicine, molecular diagnostics